Researchers in England found that MRI-assessed tumor responses to neoadjuvant therapy can help in the planning of subsequent treatments.
The study found that 72 percent of good responders to chemotherapy or radiation were alive after five years, compared with 27 percent of poor responders.
Related Articles on Rectal Cancer:
Trans-Anal Minimally Invasive Surgery Introduced in California
Study: Just One Screening Reduces Colon Cancer Risk for Middle-Aged Patients
Minimally Invasive Colorectal Surgery Cuts Clotting Risk
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
